Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2705 (LINC02705) is a member of the lincRNA class, a subset of long non-coding RNAs that are more than 200 nucleotides in length and transcribed from regions of the genome that do not overlap with protein-coding genes. LINC02705 does not encode a protein and, like other lincRNAs, is presumed to function in the regulation of gene expression, including modulation of chromatin structure, transcriptional regulation, and potentially fine-tuning the expression of neighboring protein-coding genes. There is no evidence to date that LINC02705 acts as a therapeutic target, nor are there drugs or biomarkers associated with this specific lincRNA[3][1][7].\n\nLINC02705 is not a protein, receptor, enzyme, or transport molecule, and there is currently no indication it is a direct therapeutic target. Most lincRNAs, when characterized, have regulatory functions in cellular biology rather than classic druggability as seen in receptors or enzymes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2705 (LINC02705).